To stay competitive, PMET jobs to go to FTs, said PAP.

Hello Hello … SG is a wealth hub de woh 240,000 millionaires In SG now Silver Serpants 0.3-0.5m PG and MG 0.2m Chin cai Chin cai secure 0.9-1m votes Liao (33%)
Why do only 8% of residents in S'pore own cars???
 
Malaysian motorcycles are doing deliveries, including macdonalds. Malaysians wrap their face like taliban doing grab deliveries with fake local accounts. Some went on to declare that deliver "on foot" to get shorter-distance allocations, and use PMDs, motorcycles, bicycles.

PMDs worst, they go to wakes and funerals to ask for free charging, begging that they need to get charged in order to get home.. These liars are doing this often because they bring along the whole charging kits.

Delivery Riders join dialogue with Pritam Singh to discuss platform workers issues.
https://www.straitstimes.com/singap...ritam-singh-to-discuss-platform-worker-issues
 

Despair, frustration and helplessness among delivery riders over foreigners working illegally in their midst​

Local delivery riders have been able to identify those among them working illegally by their appearance, accents and licence plates.

https://www.channelnewsasia.com/sin...llegal-workers-foreigners-frustration-5221116
More disheartening news from my industry, many labs are using Malaysian riders and vehicles to go around collecting blood samples.

Honest businesses that uses local vehicles and riders lose.
 
More disheartening news from my industry, many labs are using Malaysian riders and vehicles to go around collecting blood samples. Honest businesses that uses local vehicles and riders lose.
With over 1 million Malaysians and 650K CECAs in S'pore besides other foreigners, is it any wonder that both the highly and lowly educated SG citizens struggle to find work?
 
With over 1 million Malaysians and 650K CECAs in S'pore besides other foreigners, is it any wonder that both the highly and lowly educated SG citizens struggle to find work?
If you get more than $5000 and try to change job now, prospective company's HR will haircut one-quarter to one-third of your last drawn.
 
Sooner or later this unsustainable state of affairs will implode and all the PAP elites whom have already made enough monies will run road with their children and related connections leaving the country to rot on its own.
 

SpaceX Plans Starship Program for In-Orbit Drug Research​



SpaceX's production facility and office building in Starbase, Texas.

SpaceX's production facility and office building in Starbase, Texas.
Photographer: Michael Gonzalez/AFP/Getty Images
By Sana Pashankar, Edward Ludlow, and Kiel Porter
July 15, 2025 at 10:17 PM GMT+8
Save
Translate

Takeaways by Bloomberg AI​

SpaceX is working on a program to use its mammoth Starship rocket to develop commercial products in space, potentially opening up a new business line for the world’s most valuable private startup, according to people familiar with the matter.

Under the plan, internally called Starfall, SpaceX’s Starship rocket would bring products like pharmaceutical components to space in small, uncrewed capsules, said one of the people, who spoke on condition of anonymity because the matter is confidential.

 

Varda raises $187M to make drugs in space​

Ken Metral

Ken Metral

10 Jul 2025 — 2 min read
Cosmico - Varda raises $187M to make drugs in space
Credit: Varda Space Industries
Varda Space is pushing the boundaries of pharmaceutical production by taking the process out of Earth’s gravity well and into orbit. The company announced a $187 million Series C funding round on Thursday to accelerate its mission of using space as a unique environment for drug manufacturing.

With gravity posing significant challenges to drug crystallization and purity on Earth, Varda is betting that microgravity conditions can unlock better methods for creating biologics like proteins and antibodies. The funding will help the company build a new 10,000-square-foot lab in El Segundo, California, where scientists will identify the most promising drug candidates for space-based crystallization. This lab work will fine-tune the conditions needed in orbit, ensuring the company’s space bioreactors operate with precision.

“Our lab helps us figure out what works on Earth first, so we know exactly how to run the process in space,” said Delian Asparouhov, Varda’s co-founder. The company is working with pharmaceutical manufacturers who face challenges with crystallization, purity, and shelf life stability—issues that could be addressed through orbital manufacturing.

Beyond producing better pharmaceuticals, Varda sees major potential in creating intellectual property. By solving manufacturing problems that others cannot, Varda aims to generate patents and licensing deals across the drug industry. Asparouhov expects the new lab to significantly increase the company’s patent portfolio.

The Series C round was led by Natural Capital and Shrug Capital, with additional backing from prominent investors including Peter Thiel, Lux Capital, Khosla Ventures, and Caffeinated Capital. Asparouhov himself is a partner at Founders Fund and a former principal at Khosla Ventures.

Varda has already launched and returned three missions since 2023, and plans to complete four more this year. While its early space manufacturing modules flew aboard Rocket Lab spacecraft, the company has since brought spacecraft production in-house, building two vehicles this year with plans to double that output in 2026.
 
Back
Top